ArticleImmunologic research2022

The Janus kinase inhibitor (baricitinib) suppresses the rheumatoid arthritis active marker gliostatin/thymidine phosphorylase in human fibroblast-like synoviocytes.

Yuji Joyo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.